What is A-Mark Precious's earnings per share (EPS)?

A-Mark Precious (AMRK) reported diluted earnings per share of $0.71 for fiscal year 2025. This represents a -75.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

A-Mark Precious Financials

AMRK

Trailing 12 months to March 31, 2026

Revenue $23.0B +109.4% YoY

Net Income $80.5M +112.2% YoY

EPS (Diluted) $0.71 FY2025 annual

Free Cash Flow $206.9M +30.4% YoY

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Mar 31, 2026 Reported May 11, 2026 Currency USD FYE June

A-Mark Precious (AMRK) reported $23.0B in revenue over the twelve months to Mar 31, 2026, up 109.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AMRK FY2025 2026-08-30

A high-volume, thin-margin model now relies more on liability financing even as cash generation separates from earnings.

In FY2025, cash conversion diverged from earnings: operating cash flow was $152M against net income of $17M. Free cash flow of $142M with capital expenditures of $11M indicates the cash outcome was driven mainly by working-capital movements, not heavy reinvestment.

This is a high-volume, thin-spread model: FY2025 revenue was $11.0B, yet gross margin was only 1.9%. The spread leaves little room for a higher cost base: SG&A reached $139M while net margin compressed to 0.2%, down from FY2024.

The balance sheet expanded faster than equity: total liabilities reached $1.5B in FY2025, while debt-to-equity rose to 2.3x, pointing to greater reliance on liabilities to support the larger asset base. A current ratio of 1.6x and inventory of $795M mean short-term coverage is not equivalent to cash liquidity.

Financial Health Signals

Financial Health Score 44/100

Scored as: Banks peer group

Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of A-Mark Precious's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings

Growth

Capital

Efficiency

Not available for A-Mark Precious, and counted as zero in the overall score.

Credit Quality

Not available for A-Mark Precious, and counted as zero in the overall score.

Stability

Piotroski F-Score Partial

4/8

A-Mark Precious passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

8.80x

For every $1 of reported earnings, A-Mark Precious generates $8.80 in operating cash flow ($152.3M OCF vs $17.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$11.0B

YoY+13.2%

5Y CAGR+15.0%

A-Mark Precious generated $11.0B in revenue in fiscal year 2025. This represents an increase of 13.2% from the prior year.

Net Income

$17.3M

YoY-74.7%

5Y CAGR-10.7%

A-Mark Precious reported $17.3M in net income in fiscal year 2025. This represents a decrease of 74.7% from the prior year.

EPS (Diluted)

$0.71

YoY-75.0%

A-Mark Precious earned $0.71 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 75.0% from the prior year.

EBITDA

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

$141.7M

YoY+163.9%

5Y CAGR+24.6%

A-Mark Precious generated $141.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 163.9% from the prior year.

Cash & Debt

$77.7M

YoY+59.8%

5Y CAGR+8.2%

10Y CAGR+14.0%

A-Mark Precious held $77.7M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding

25M

YoY+7.3%

A-Mark Precious had 25M shares outstanding in fiscal year 2025. This represents an increase of 7.3% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin

1.9%

YoY+0.1pp

5Y CAGR+0.7pp

A-Mark Precious's gross margin was 1.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.1 percentage points from the prior year.

Net Margin

0.2%

YoY-0.6pp

5Y CAGR-0.4pp

A-Mark Precious's net profit margin was 0.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.6 percentage points from the prior year.

Return on Equity

2.7%

YoY-8.6pp

5Y CAGR-27.5pp

A-Mark Precious's ROE was 2.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 8.6 percentage points from the prior year.

Operating Margin

Not reported for fiscal year 2025.

Capital Allocation

Capital Expenditures

$10.7M

YoY+47.2%

5Y CAGR+66.4%

10Y CAGR+19.6%

A-Mark Precious invested $10.7M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 47.2% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

Share Buybacks

Not reported for fiscal year 2025.

AMRK Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

AMRK quarterly income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	$23.0B	$11.0B+13.2%	$9.7B+4.4%	$9.3B+13.8%	$8.2B+7.2%	$7.6B+39.4%	$5.5B+14.2%	$4.8B	N/A	N/A	N/A	N/A	N/A	N/A	$7.8B
Cost of Revenue	$22.6B	$10.8B+13.0%	$9.5B+5.9%	$9.0B+13.9%	$7.9B+6.7%	$7.4B+37.2%	$5.4B+13.5%	$4.8B	N/A	N/A	N/A	N/A	N/A	N/A	$7.8B
Gross Profit	$424.5M	$210.9M+21.7%	$173.3M-41.2%	$294.7M+12.6%	$261.8M+24.5%	$210.2M+213.9%	$67.0M+109.6%	$32.0M+8.5%	$29.4M-6.0%	$31.3M-9.2%	$34.5M+40.9%	$24.5M-10.7%	$27.4M-9.6%	$30.3M+14.8%	$26.4M
SG&A Expenses	$251.1M	$139.2M+55.0%	$89.8M+5.3%	$85.3M+11.3%	$76.6M+59.6%	$48.0M+30.6%	$36.8M+13.1%	$32.5M-2.7%	$33.4M+43.1%	$23.3M+5.0%	$22.2M+29.8%	$17.1M+10.0%	$15.6M+10.3%	$14.1M-9.3%	$15.6M
Interest Expense	$60.8M	$46.2M+16.9%	$39.5M+25.4%	$31.5M+43.4%	$22.0M+10.7%	$19.9M+5.3%	$18.9M+10.0%	$17.1M+23.4%	$13.9M+37.3%	$10.1M+60.1%	$6.3M+46.6%	$4.3M+9.8%	$3.9M+12.7%	$3.5M-18.0%	$4.2M
Income Tax	$23.5M	$5.4M-60.5%	$13.7M-70.4%	$46.4M+39.2%	$33.3M+4.6%	$31.9M+399.1%	$6.4M+529.3%	$1.0M+12587.5%	$8K-99.8%	$3.7M-40.9%	$6.3M+200.1%	$2.1M-60.2%	$5.3M-34.5%	$8.1M-3.5%	$8.3M
Net Income	$80.5M	$17.3M-74.7%	$68.5M-56.2%	$156.4M+18.0%	$132.5M-17.0%	$159.6M+423.2%	$30.5M+1271.2%	$2.2M	N/A	N/A	N/A	N/A	$8.3M-34.0%	$12.5M+18.4%	$10.6M
EPS (Diluted)	—	$0.71-75.0%	$2.84-55.2%	$6.34+16.3%	$5.45-38.8%	$8.90	$4.31+1290.3%	$0.31+164.6%	-$0.48-148.0%	$1.00-23.1%	$1.30+30.0%	$1.00-8.3%	$1.09-31.4%	$1.59+23.3%	$1.29

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Revenue	$10.4B+59.8%	$6.5B+76.0%	$3.7B+46.5%	$2.5B-16.5%	$3.0B+9.7%	$2.7B+1.0%	$2.7B+7.5%	$2.5B
Cost of Revenue	$10.2B+59.4%	$6.4B+76.9%	$3.6B+48.5%	$2.4B-18.1%	$3.0B+10.0%	$2.7B+1.0%	$2.7B+7.6%	$2.5B
Gross Profit	$176.6M+89.1%	$93.4M+28.1%	$72.9M-10.8%	$81.7M+99.2%	$41.0M-8.4%	$44.8M+3.0%	$43.4M+1.1%	$43.0M
SG&A Expenses	$78.0M+30.5%	$59.8M-0.1%	$59.8M+12.0%	$53.4M+59.9%	$33.4M+29.7%	$25.8M-3.2%	$26.6M+17.2%	$22.7M
Interest Expense	$19.0M+17.1%	$16.3M+29.0%	$12.6M-2.3%	$12.9M-0.4%	$13.0M+25.0%	$10.4M+3.8%	$10.0M+3.7%	$9.6M
Income Tax	$17.7M+687.7%	$2.2M+240.8%	$660K-76.9%	$2.9M+332.3%	-$1.2M-160.3%	$2.0M+16.4%	$1.8M-42.3%	$3.0M
Net Income	$59.5M+411.2%	$11.6M+1339.2%	-$939K-109.1%	$10.3M+220.8%	-$8.5M-230.3%	$6.6M-27.0%	$9.0M-71.0%	$30.9M
EPS (Diluted)	$2.09+354.3%	$0.46+1250.0%	-$0.04	N/A	-$0.36-233.3%	$0.27-27.0%	$0.37	N/A

Not reported in any period shown, so not listed: R&D Expenses, Operating Income.

AMRK Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

AMRK quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Total Assets	$2.2B+21.2%	$1.8B+18.3%	$1.5B+7.1%	$1.4B+21.1%	$1.2B+57.2%	$758.0M+7.5%	$705.4M-5.1%	$743.0M+55.3%	$478.5M+9.5%	$437.1M+33.8%	$326.7M+7.1%	$305.1M-1.4%	$309.6M	N/A
Current Assets	$1.7B+20.9%	$1.4B+13.8%	$1.3B+7.3%	$1.2B+22.5%	$964.2M+35.0%	$714.0M+6.8%	$668.9M-5.4%	$707.0M+58.2%	$447.0M+6.9%	$418.3M+33.8%	$312.6M+5.9%	$295.3M-1.7%	$300.4M	N/A
Cash & Equivalents	$77.7M+59.8%	$48.6M+23.7%	$39.3M+4.1%	$37.8M-62.7%	$101.4M+93.8%	$52.3M+528.9%	$8.3M+32.3%	$6.3M-51.8%	$13.1M-23.8%	$17.1M-18.1%	$20.9M+58.6%	$13.2M-38.8%	$21.6M+91.3%	$11.3M
Inventory	$794.8M+37.2%	$579.4M-10.3%	$645.8M+40.9%	$458.3M+78.4%	$257.0M+4.2%	$246.6M+24.3%	$198.4M+19.4%	$166.2M+11.3%	$149.3M-19.6%	$185.7M+22.1%	$152.1M+0.7%	$150.9M+21.9%	$123.8M	N/A
Accounts Receivable	$137.7M+276.3%	$36.6M+3.8%	$35.2M-63.7%	$97.0M+9.0%	$89.0M+81.1%	$49.1M+82.7%	$26.9M-25.0%	$35.9M-8.8%	$39.3M-9.3%	$43.3M+44.2%	$30.0M	N/A	N/A	N/A
Goodwill	$228.7M+14.4%	$199.9M+98.1%	$100.9M0.0%	$100.9M0.0%	$100.9M+1036.6%	$8.9M0.0%	$8.9M0.0%	$8.9M0.0%	$8.9M+92.2%	$4.6M-5.4%	$4.9M0.0%	$4.9M0.0%	$4.9M	N/A
Total Liabilities	$1.5B+29.7%	$1.2B+23.4%	$945.2M-0.7%	$952.2M+15.0%	$827.6M+26.7%	$653.1M+3.2%	$632.8M-6.1%	$673.9M+66.2%	$405.5M+8.5%	$373.8M+38.1%	$270.7M+5.9%	$255.7M-0.3%	$256.4M	N/A
Current Liabilities	$1.1B+26.1%	$883.8M-4.4%	$924.1M+10.4%	$836.7M+17.9%	$709.6M+27.4%	$556.8M+2.9%	$540.9M-18.8%	$665.9M+64.7%	$404.4M+10.3%	$366.6M+35.9%	$269.8M+5.5%	$255.6M-0.1%	$255.8M	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	$91.9M	$0	$0	N/A	N/A	N/A	N/A	N/A
Total Equity	$649.5M+6.9%	$607.6M+1.4%	$599.1M+22.6%	$488.6M+34.7%	$362.6M+259.0%	$101.0M+45.0%	$69.7M+6.0%	$65.7M-5.6%	$69.6M+9.9%	$63.3M+13.1%	$56.0M+13.2%	$49.5M-7.1%	$53.3M-4.2%	$55.6M
Retained Earnings	$464.1M-0.6%	$466.8M+5.9%	$440.6M+36.9%	$321.8M+51.8%	$212.1M+188.0%	$73.6M+70.7%	$43.1M+5.4%	$40.9M-11.1%	$46.0M+12.1%	$41.0M+22.7%	$33.4M+23.5%	$27.1M-6.0%	$28.8M	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Total Assets	$4.2B+9.5%	$3.8B+47.8%	$2.6B+16.4%	$2.2B+1.5%	$2.2B+16.8%	$1.9B-7.9%	$2.0B+11.0%	$1.8B
Current Assets	$3.7B+9.8%	$3.3B+58.3%	$2.1B+21.1%	$1.7B-0.8%	$1.8B+18.0%	$1.5B-9.5%	$1.6B+14.1%	$1.4B
Cash & Equivalents	$143.6M-5.6%	$152.1M+70.4%	$89.2M+14.8%	$77.7M-32.0%	$114.3M+202.8%	$37.8M-19.5%	$46.9M-3.5%	$48.6M
Inventory	$1.3B+28.0%	$1.0B+21.9%	$846.1M+6.4%	$794.8M+4.6%	$759.6M+18.3%	$642.3M-12.7%	$735.6M+27.0%	$579.4M
Accounts Receivable	$168.4M-69.9%	$558.8M+97.4%	$283.1M+105.6%	$137.7M+10.3%	$124.9M+265.7%	$34.1M-52.5%	$71.8M+96.3%	$36.6M
Goodwill	$243.7M+6.6%	$228.7M0.0%	$228.7M0.0%	$228.7M+5.4%	$216.9M+8.5%	$199.9M0.0%	$199.9M0.0%	$199.9M
Total Liabilities	$3.3B+5.3%	$3.1B+64.9%	$1.9B+24.4%	$1.5B+1.8%	$1.5B+23.5%	$1.2B-11.8%	$1.4B+17.0%	$1.2B
Current Liabilities	$3.1B+13.3%	$2.8B+78.5%	$1.5B+38.5%	$1.1B-1.3%	$1.1B+19.5%	$944.6M-4.5%	$989.6M+12.0%	$883.8M
Total Equity	$847.3M+29.6%	$653.8M+1.5%	$644.0M-0.9%	$649.5M+0.9%	$643.6M+5.0%	$612.7M+0.3%	$611.1M+0.6%	$607.6M
Retained Earnings	$518.5M+11.6%	$464.8M+1.5%	$458.1M-1.3%	$464.1M+1.2%	$458.7M-3.1%	$473.1M+1.4%	$466.6M-0.1%	$466.8M

Not reported in any period shown, so not listed: Long-Term Debt.

AMRK Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

AMRK quarterly cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Operating Cash Flow	$220.0M	$152.3M+150.0%	$60.9M+300.9%	-$30.3M+66.0%	-$89.2M-69.3%	-$52.7M-209.8%	$47.9M+429.8%	-$14.5M-290.1%	$7.6M+178.2%	-$9.8M+82.6%	-$56.2M-1097.1%	-$4.7M+72.0%	-$16.7M-1288.5%	-$1.2M-104.7%	$25.4M
Capital Expenditures	$13.1M	$10.7M+47.2%	$7.3M+51.7%	$4.8M+66.1%	$2.9M+36.3%	$2.1M+152.8%	$836K+70.6%	$490K-62.8%	$1.3M-41.9%	$2.3M+54.5%	$1.5M-17.8%	$1.8M+76.5%	$1.0M+110.6%	$480K-15.5%	$568K
Free Cash Flow	$206.9M	$141.7M+163.9%	$53.7M+252.9%	-$35.1M+61.9%	-$92.0M-68.1%	-$54.8M-216.3%	$47.1M+413.5%	-$15.0M-337.4%	$6.3M+152.5%	-$12.0M+79.1%	-$57.6M-789.9%	-$6.5M+63.5%	-$17.8M-953.1%	-$1.7M-106.8%	$24.8M
Investing Cash Flow	-$124.8M	-$104.7M-64.6%	-$63.6M-1029.9%	$6.8M+111.3%	-$60.6M+53.6%	-$130.4M-367.3%	$48.8M+429.4%	-$14.8M+17.0%	-$17.8M+51.1%	-$36.5M-20.7%	-$30.2M-125.6%	-$13.4M-137.8%	-$5.6M-1073.3%	-$480K+15.5%	-$568K
Financing Cash Flow	-$65.9M	-$18.6M-255.1%	$12.0M-52.1%	$25.0M-70.9%	$86.1M-62.9%	$232.1M+540.4%	-$52.7M-268.0%	$31.4M+817.7%	$3.4M-91.9%	$42.2M-48.9%	$82.6M+219.9%	$25.8M+84.3%	$14.0M+16.9%	$12.0M+152.2%	-$22.9M
Dividends Paid	$20.5M	$18.8M-55.1%	$41.8M+11.7%	$37.5M+65.5%	$22.6M+6.9%	$21.2M	N/A	$0-100.0%	$1.7M-20.0%	$2.1M+26.0%	$1.7M+140.0%	$698K-93.0%	$10.0M-33.3%	$15.0M	$0
Share Buybacks	N/A	N/A	$22.3M+128.5%	$9.8M	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Operating Cash Flow	$235K+100.6%	-$42.6M-121.8%	$195.4M+191.8%	$67.0M-34.9%	$102.8M-6.6%	$110.1M+186.3%	-$127.5M-253.9%	$82.8M
Capital Expenditures	$3.2M-19.1%	$4.0M+102.5%	$2.0M-49.4%	$3.9M+57.7%	$2.5M-33.2%	$3.7M+509.7%	$607K-77.8%	$2.7M
Free Cash Flow	-$3.0M+93.6%	-$46.6M-124.1%	$193.4M+206.7%	$63.1M-37.2%	$100.4M-5.6%	$106.4M+183.0%	-$128.1M-259.9%	$80.1M
Investing Cash Flow	-$24.1M+14.4%	-$28.1M-146.7%	-$11.4M+81.4%	-$61.2M-13.4%	-$54.0M-983.1%	-$5.0M-132.2%	$15.5M+404.2%	-$5.1M
Financing Cash Flow	$15.4M-88.5%	$133.6M+177.4%	-$172.5M-307.2%	-$42.4M-253.0%	$27.7M+124.2%	-$114.2M-203.5%	$110.3M+271.6%	-$64.3M
Dividends Paid	$5.7M+14.9%	$4.9M-0.8%	$5.0M+1.3%	$4.9M+6.8%	$4.6M-0.7%	$4.6M+0.2%	$4.6M+1.2%	$4.6M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0

AMRK Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

AMRK quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Gross Margin	1.9%+0.1pp	1.8%-1.4pp	3.2%0.0pp	3.2%+0.4pp	2.8%+1.5pp	1.2%+0.6pp	0.7%	N/A	N/A	N/A	N/A	N/A	N/A	0.3%
Net Margin	0.2%-0.6pp	0.7%-1.0pp	1.7%+0.1pp	1.6%-0.5pp	2.1%+1.5pp	0.6%+0.5pp	0.1%	N/A	N/A	N/A	N/A	N/A	N/A	0.1%
Return on Equity	2.7%-8.6pp	11.3%-14.8pp	26.1%-1.0pp	27.1%-16.9pp	44.0%+13.8pp	30.2%+27.0pp	3.2%	N/A	N/A	N/A	N/A	16.7%-6.8pp	23.5%+4.5pp	19.0%
Return on Assets	0.8%-3.0pp	3.8%-6.4pp	10.1%+0.9pp	9.2%-4.2pp	13.4%+9.4pp	4.0%+3.7pp	0.3%	N/A	N/A	N/A	N/A	2.7%-1.3pp	4.0%	N/A
Current Ratio	1.56-0.1x	1.63+0.3x	1.370.0x	1.41+0.1x	1.36+0.1x	1.280.0x	1.24+0.2x	1.060.0x	1.110.0x	1.140.0x	1.160.0x	1.160.0x	1.17	N/A
Debt-to-Equity	2.33+0.4x	1.92+0.3x	1.58-0.4x	1.95-0.3x	2.28-4.2x	6.47+5.1x	1.32+1.3x	0.000.0x	0.00-5.9x	5.91+1.1x	4.84-0.3x	5.17+0.4x	4.81	N/A
FCF Margin	1.3%+0.7pp	0.5%+0.9pp	-0.4%+0.8pp	-1.1%-0.4pp	-0.7%-1.6pp	0.9%+1.2pp	-0.3%	N/A	N/A	N/A	N/A	N/A	N/A	0.3%

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Gross Margin	1.7%+0.3pp	1.4%-0.5pp	2.0%-1.3pp	3.3%+1.9pp	1.4%-0.3pp	1.6%0.0pp	1.6%-0.1pp	1.7%
Net Margin	0.6%+0.4pp	0.2%+0.2pp	0.0%-0.4pp	0.4%+0.7pp	-0.3%-0.5pp	0.2%-0.1pp	0.3%-0.9pp	1.2%
Return on Equity	7.0%+5.2pp	1.8%+1.9pp	-0.1%-1.7pp	1.6%+2.9pp	-1.3%-2.4pp	1.1%-0.4pp	1.5%-3.6pp	5.1%
Return on Assets	1.4%+1.1pp	0.3%+0.4pp	0.0%-0.5pp	0.5%+0.9pp	-0.4%-0.7pp	0.4%-0.1pp	0.4%-1.2pp	1.7%
Current Ratio	1.180.0x	1.21-0.2x	1.37-0.2x	1.560.0x	1.560.0x	1.58-0.1x	1.660.0x	1.63
Debt-to-Equity	3.86-0.9x	4.75+1.8x	2.92+0.6x	2.330.0x	2.31+0.3x	1.96-0.3x	2.23+0.3x	1.92
FCF Margin	0.0%+0.7pp	-0.7%-6.0pp	5.3%+2.8pp	2.5%-0.8pp	3.3%-0.5pp	3.9%+8.6pp	-4.7%-7.9pp	3.2%

Not reported in any period shown, so not listed: Operating Margin.

Similar Companies

BITFUFU FUFU

$223.3M

Coincheck Group CNCK

$404.7M

ALPS/Dorsey Wright Sector Momentum ETF SWIN

$614.0M

Oppenheimer Hld OPY

$1.3B

Cango Inc CANG

$91.5M

Where A-Mark Precious Ranks

Frequently Asked Questions

What is A-Mark Precious's annual revenue?

A-Mark Precious (AMRK) reported $11.0B in total revenue for fiscal year 2025. This represents a 13.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is A-Mark Precious's revenue growing?

A-Mark Precious (AMRK) revenue grew by 13.2% year-over-year, from $9.7B to $11.0B in fiscal year 2025.

Is A-Mark Precious profitable?

Yes, A-Mark Precious (AMRK) reported a net income of $17.3M in fiscal year 2025, with a net profit margin of 0.2%.

What is A-Mark Precious's gross margin?

A-Mark Precious (AMRK) had a gross margin of 1.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is A-Mark Precious's net profit margin?

A-Mark Precious (AMRK) had a net profit margin of 0.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is A-Mark Precious's return on equity (ROE)?

A-Mark Precious (AMRK) has a return on equity of 2.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is A-Mark Precious's free cash flow?

A-Mark Precious (AMRK) generated $141.7M in free cash flow during fiscal year 2025. This represents a 163.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is A-Mark Precious's operating cash flow?

A-Mark Precious (AMRK) generated $152.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are A-Mark Precious's total assets?

A-Mark Precious (AMRK) had $2.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are A-Mark Precious's capital expenditures?

A-Mark Precious (AMRK) invested $10.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does A-Mark Precious have outstanding?

A-Mark Precious (AMRK) had 25M shares outstanding as of fiscal year 2025.

What is A-Mark Precious's current ratio?

A-Mark Precious (AMRK) had a current ratio of 1.56 as of fiscal year 2025, which is generally considered healthy.

What is A-Mark Precious's debt-to-equity ratio?

A-Mark Precious (AMRK) had a debt-to-equity ratio of 2.33 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is A-Mark Precious's return on assets (ROA)?

A-Mark Precious (AMRK) had a return on assets of 0.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is A-Mark Precious's Piotroski F-Score?

A-Mark Precious (AMRK) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are A-Mark Precious's earnings high quality?

A-Mark Precious (AMRK) has an earnings quality ratio of 8.80x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is A-Mark Precious?

A-Mark Precious (AMRK) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its banks peer group. The score is a 0-100 composite of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.